Narodowy Instytut Onkologii

Warsaw 02-781

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Colorectal Cancer (CRC), Diffuse Large B-cell Lymphoma (DLBCL), Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma, Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

Studies at this site

• A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma — Recruiting now
• A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma — Recruiting now
• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors — Running, not enrolling